GENE-11. SHARED LONG NON-CODING RNA DYSREGULATION IN HISTONE H3 K27M GLIOMAS AND PF-A EPENDYMOMAS. (23rd April 2019)
- Record Type:
- Journal Article
- Title:
- GENE-11. SHARED LONG NON-CODING RNA DYSREGULATION IN HISTONE H3 K27M GLIOMAS AND PF-A EPENDYMOMAS. (23rd April 2019)
- Main Title:
- GENE-11. SHARED LONG NON-CODING RNA DYSREGULATION IN HISTONE H3 K27M GLIOMAS AND PF-A EPENDYMOMAS
- Authors:
- Sanders, Lauren
Cheney, Allison
Field, Andrew
Beale, Holly
Kephart, Ellen
Learned, Katrina
Bjork, Isabel
Durbin, Ann
Lyle, Geoff
Pfeil, Jacob
Salama, Sofie
Haussler, David
Vaske, Olena - Abstract:
- Abstract: Diffuse pediatric gliomas harboring a Histone H3 K27M mutation are significantly more aggressive than H3-wild type gliomas and demonstrate global hypomethylation at the K27 residue 1 . As a result, these tumors show global aberrant gene expression, resulting in a primitive, stem-like proliferative cell population 2 . Posterior fossa (PF) ependymomas, on the other hand, harbor few significantly recurrent somatic mutations, but PF-A and PF-B subgroups have been defined on the basis of epigenetic differences 3 . Compared to PF-B, the PF-A subgroup demonstrates H3K27 hypomethylation, aberrant gene expression and aggressive tumor growth 4, 5 . We recently identified a set of long non-coding RNA (lncRNA) that are transiently expressed in early brain development 6, and hypothesized that H3K27M gliomas and PF-A ependymomas may share methylation-related dysregulation of long non-coding RNA (lncRNA) networks responsible for maintaining normal differentiation programs. Here we describe a network of regulatory lncRNA with increased expression in both H3K27M gliomas and PF-A ependymomas, as compared to H3-WT gliomas and PF-B ependymomas. We demonstrate that increased expression of this lncRNA network correlates with the over-expression of signaling pathways involved in maintaining a non-differentiated, proliferative phenotype and driving tumorigenesis. We hypothesize that in both H3K27M gliomas and PF-A ependymomas, aberrant global methylation may be driving lncRNA to activateAbstract: Diffuse pediatric gliomas harboring a Histone H3 K27M mutation are significantly more aggressive than H3-wild type gliomas and demonstrate global hypomethylation at the K27 residue 1 . As a result, these tumors show global aberrant gene expression, resulting in a primitive, stem-like proliferative cell population 2 . Posterior fossa (PF) ependymomas, on the other hand, harbor few significantly recurrent somatic mutations, but PF-A and PF-B subgroups have been defined on the basis of epigenetic differences 3 . Compared to PF-B, the PF-A subgroup demonstrates H3K27 hypomethylation, aberrant gene expression and aggressive tumor growth 4, 5 . We recently identified a set of long non-coding RNA (lncRNA) that are transiently expressed in early brain development 6, and hypothesized that H3K27M gliomas and PF-A ependymomas may share methylation-related dysregulation of long non-coding RNA (lncRNA) networks responsible for maintaining normal differentiation programs. Here we describe a network of regulatory lncRNA with increased expression in both H3K27M gliomas and PF-A ependymomas, as compared to H3-WT gliomas and PF-B ependymomas. We demonstrate that increased expression of this lncRNA network correlates with the over-expression of signaling pathways involved in maintaining a non-differentiated, proliferative phenotype and driving tumorigenesis. We hypothesize that in both H3K27M gliomas and PF-A ependymomas, aberrant global methylation may be driving lncRNA to activate and maintain stem-like states in early neural development, suggesting similarities in epigenetically driven, developmental origins for both tumor types. References: 1. Chan KM, Fang D, Gan H, et al. Genes Dev. 2013;27(9):985–90; 2. Filbin MG, Tirosh I, Hovestadt V, et al. Science. 2018;360(6386):331–5; 3. Witt H, Mack SC, Ryzhova M, et al. Cancer cell. 2011;20(2):143–57; 4. Bayliss J, Mukherjee P, Lu C, et al. Sci. Transl. Med. 2016;8(366):366ra161; 5. Mack SC, Witt H, Piro RM, et al. Nature. 2014;506(7489):445; 6. Field AR, Jacobs FM, Fiddes IT, et al. bioRxiv. 2017:232553. … (more)
- Is Part Of:
- Neuro-oncology. Volume 21(2019)Supplement 2
- Journal:
- Neuro-oncology
- Issue:
- Volume 21(2019)Supplement 2
- Issue Display:
- Volume 21, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 21
- Issue:
- 2
- Issue Sort Value:
- 2019-0021-0002-0000
- Page Start:
- ii83
- Page End:
- ii83
- Publication Date:
- 2019-04-23
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noz036.082 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12038.xml